Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Healthy
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 65 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04176133
- Collaborators
- Genome Protection, Inc
- Investigators
- Principal Investigator: Robert Pignolo, MD, PhD Mayo Clinic
Get Well Soon